CD8+ cytotoxic T lymphocytes were long considered the most potent anti-tumor effectors in the adaptive immune system, but lately, the focus has shifted towards the importance of CD4+ T helper lymphocytes as an opportunity to achieve tumor recognition and T cell infiltration in an immunosuppressive TME. This evidence concerns the gene CD4 and neoplasm.